US Patent 11097013 Anti-HER2 antibody-maytansine conjugates and methods of use thereof
Patent 11097013 was granted and assigned to Redwood Bioscience on August, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 26, 2018
Date of Patent
August 24, 2021
Patent Applicant
Patent Application Number
20180926
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11097013 Anti-HER2 antibody-maytansine conjugates and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
